World Health Organization Issues Warning Over Acute Scarcity of Obesity Medications

Fewer than one in 10 people who could benefit from weight-loss injections including Wegovy are able to get them, states the WHO as it publishes its initial guidance on the drugs.

Considering in excess of 1,000,000,000 people worldwide now classified as obese, it is calling for increased and just availability to this class of drugs.

Per projections, over two billion are projected to be living with obesity by 2030 without intervention.

"The latest guidance affirms that excess weight is a long-term condition that can be addressed with holistic and ongoing care," stated the agency's head Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and logistical bottlenecks are significant obstacles to universal availability to the treatments that can aid individuals in losing significant weight, says the agency.

Skinny Jab Shortage

Even in the current most favorable scenario, the manufacturing of these medications could only cover approximately 100 million people – less than 10% of the global need, according to the WHO.

The guideline urges nations and manufacturers to expand availability, through measures such as licensing agreements.

Exclusive production rights on semaglutide – the main component of Novo Nordisk's Wegovy – is scheduled to end in several countries in 2026.

How Obesity Jabs Operate

GLP-1 drugs mimick a natural hormone to reduce digestion speed, reduce hunger and boost the sense of being full so users consume fewer calories.

Individuals commonly begin shedding pounds after several weeks of beginning the weekly injections.

Research indicates people may put most of the weight back on within a year of halting the drug, because their typical food cravings return.

Being carrying excess weight increases your risk for contracting medical conditions, including diabetes, heart disease, stroke, and certain malignancies.

Excess weight affects individuals in countries worldwide and was responsible for over three and a half million deaths worldwide in 2024, per the health agency.

Alexander Cole
Alexander Cole

Lena Visser is a landscape architect and sustainability advocate, sharing expert advice on urban gardening and eco-friendly living.